ロード中...
Clinical pharmacology of prochlorperazine in healthy young males.
1. The pharmacokinetics and pharmacodynamics of prochlorperazine (PCZ) have been studied in healthy young males following single 12.5 mg i.v. and 50 mg oral doses, and during repeated doses (25 mg twice daily) for 14 days. 2. Oral bioavailability was low and an N-desmethyl metabolite was detected. P...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1991
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1368546/ https://ncbi.nlm.nih.gov/pubmed/1768559 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|